BIBLIOGRAPHIC RECORD

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Ellen James; David Erritzøe; Tiffanie Benway; Zelah Joel; Christopher Timmermann; Meghan Good; Claudio Agnorelli; Brandon Weiss; Tommaso Barba; Graham Campbell; Michelle Baker Jones; Charlotte Hughes; Helen Topping; Malcolm Boyce; Carol Routledge
Source of metadata
OpenAlex
Year recorded
2024

Public identifiers and source

Open the source record

Reference

Ellen James; David Erritzøe; Tiffanie Benway; Zelah Joel; Christopher Timmermann; Meghan Good; Claudio Agnorelli; Brandon Weiss; Tommaso Barba; Graham Campbell; Michelle Baker Jones; Charlotte Hughes; Helen Topping; Malcolm Boyce; Carol Routledge. (2024). Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial. https://openalex.org/W4390754503

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-d3f064b11d43f40337356ca819e99300/